11.10.2017
- Swiss specialty chemicals company Lonza has acquired Shire’s clinical-stage mammalian manufacturing site in Hayward, California, USA, boosting its cGMP capacity and supplementing...
08.09.2017
- Following all regulatory approvals, French drugmaker Sanofi has completed the acquisition of Protein Sciences, a US vaccines biotech based in Meriden, Connecticut. The deal...
07.09.2017
- Germany’s Merck KGaA is weighing options for its Consumer Health business, which it says has a strong market position but needs more investment to grow sufficiently. The chemicals...
25.08.2017
- Mylan has finalized a $465 million settlement with the US Department of Justice (DoJ) resolving claims relating to its EpiPen emergency allergy treatment. The DoJ’s announcement of...
11.08.2017
- Sanofi has sued US Merck, alleging infringement of two patents related to an insulin drug. The French drugmaker said the action was triggered by a notification received from Merck...
04.08.2017
- French drugmaker Sanofi has signed a research and licensing deal with Belgian biopharmaceutical company Ablynx, initially focusing on the development and commercialization of...
13.07.2017
- French drugmaker Sanofi is gaining access to a new type of flu vaccine after agreeing to buy Protein Sciences, a privately held vaccines biotechnology company based in Meriden...
10.05.2017
- French pharma company Sanofi has signed a research collaboration and license option agreement with Scottish drug design company Exscientia that focuses on metabolic diseases such...
